Speakers
Navigate the 2022 Speakers Using the Buttons Below:
Workshop Day Speakers
Adrian Bot
Chief Scientific Officer & Executive Vice President, Research & Development
Capstan Therapeutics
Colleen Delaney
Founder & Chief Scientific Officer, Executive Vice President of Research & Development
Deverra Therapeutics
Daniel Abate-Daga
Associate Professor
H. Lee Moffitt Cancer Center & Research Institute & University of South Florida
Neil Sheppard
Director, T Cell Engineering Lab
University of Pennsylvania, Center for Cellular Immunotherapies
Bootcamp Speakers
Adrian Bot
Chief Scientific Officer & Executive Vice President, Research & Development
Capstan Therapeutics
Marko Radic
Associate Professor of Microbiology, Immunology & Biochemistry
University of Tennessee Health Science Center
Focus Day Speakers
Lan Cao
Vice President, Head of Cell Therapy Innovation, Oncology Cell Therapy & Therapeutic Area Unit
Takeda
Neil Sheppard
Director, T Cell Engineering Lab
University of Pennsylvania, Center for Cellular Immunotherapies
Tech Slam Speakers
Plenary Speakers
Adrian Bot
Chief Scientific Officer & Executive Vice President, Research & Development
Capstan Therapeutics
Dominic Clarke
Chief Technical Officer, Cell & Gene Therapy
AllCells, A Discovery Life Sciences Company
Discovery Track Speakers
Translation Track Speakers
Archana Thakur
Associate Professor of Medicine, Director of Human Cellular Therapeutics cGMP Core
University of Virginia, School of Medicine
Paul Rennert
Acting Chief Executive Officer, President, Chief Scientific Officer
Aleta Biotherapeutics
Vita Golubovskaya
Senior Director, Research & Development, Business Development
ProMab Biotechnologies
Clinical Management Track Speakers
Gaurav Nurala
Professor Pediatric Oncology & Health Sciences, Department of Medical Oncology
Tata Memorial Center, Homi Bhabha National Institute
Jim Wise
Vice President, Head of Center for Immuno-Oncology, Cellular & Gene Therapy
ICON Global Operations
Muneesh Tewari
Professor of Internal Medicine & Biomedical Engineering, Anderson-Sprague Memorial Research Professor
University of Michigan
Paul Rennert
Acting Chief Executive Officer, President, Chief Scientific Officer
Aleta Biotherapeutics
Early Phase Development Track Speakers
Manufacturing Track Speakers
Albeena Nisar
Scientific Officer, CAR-T Cell Therapy Centre & cGMP Cell Therapy Centre
Tata Memorial Center, Homi Bhabha National Institute
Charles Mooney
Vice President Bio-Development Oklahoma Blood Institute & Member
Blood Centers of America & BCA CT Network
Eytan Abraham
VP & Business Head of Cell Therapy, Gene Therapy, & Nucleic Acid Franchises
Resilience
Michael Birnbaum
Associate Professor, Department of Biological Engineering
Massachusetts Institute of Technology
CMC/Analytics Track Speakers
Isabelle Riviere
Director, Cell Therapy & Cell Engineering Laboratory
Memorial Sloan Kettering Cancer Center
Kent Amsbery
Director, Advanced Therapy Product Development Regulatory Sciences, Specialty Solutions
Cardinal Health
Matthew Hewitt
Executive Direvtor – Scientific Solutions, Cell & Gene Therapy
Charles River Laboratories
Logistics Track Speakers
Melissa Sebok
Executive Director – Product, Client & Business Development, Direct Patient Care & Emerging Offerings
American Red Cross Biomedical Services
Susan Li
Director of Customer Solutions, BioServices & Speciality Logistics
Thermo Fisher Scientific
Tracy Turner
Scientist, Formulation and Cryobiology, Cell Therapy Development Organization
Bristol Myers Squibb
Market Access Track Speakers
Jodie Wehling
Vice President, Market Access, Payer Marketing & Strategic Accounts
Atara Biotherapeutics
Shirley Bartido
Director, Global Regulatory Affairs Cell Therapy Oncology
Takeda Pharmaceutical Company
